Table 1.
Variables | Total (N = 160) |
---|---|
Gender, n (%) | |
Male | 52 (32.5) |
Female | 108 (67.5) |
Age (years), median (min-max) | 58 (22–78) |
NAFLD, n (%) | |
Yes | 115 (71.9) |
No | 45 (28.1) |
SIBO, n (%) | |
Yes | 55 (34.4) |
No | 105 (65.6) |
Obesity, n (%) | |
Yes | 107 (66.9) |
No | 53 (33.1) |
DM, n (%) | |
Yes | 120 (75) |
No | 40 (25) |
Dyslipidemia, n (%) | |
Yes | 129 (80.6) |
No | 31 (19.4) |
Metabolic Syndrome, n (%) | |
Yes | 122 (76.3) |
No | 38 (23.8) |
Central Obesity, n (%) | |
Yes | 149 (93.1) |
No | 11 (6.9) |
Fibrosis Degree, n (%) | |
F0-F1 | 89 (77.4) |
F2-F4 | 26 (22.6) |
Steatosis Degree, n (%) | |
S0 | 41 (26.4) |
S1 | 10 (6.4) |
S2 | 4 (2.5) |
S3 | 60 (38.7) |
Significant Steatosis, n (%) | |
Yes | 71 (61.7) |
No | 44 (38.3) |
SIBO Small Intestinal Bacterial Overgrowth, NAFLD Non-Alcoholic Fatty Liver Disease, DM Diabetes Mellitus, PR Prevalence Ratio, CI Confidence Interval